{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:33:14Z","timestamp":1793395994251,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:00:00Z","timestamp":1715990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["UG3\/UH3 HL147352"],"award-info":[{"award-number":["UG3\/UH3 HL147352"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K99\/R00 HL151806"],"award-info":[{"award-number":["K99\/R00 HL151806"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K99\/R00 HL157552"],"award-info":[{"award-number":["K99\/R00 HL157552"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56 AI175206"],"award-info":[{"award-number":["R56 AI175206"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56 AI175206"],"award-info":[{"award-number":["R56 AI175206"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["EGAN641558"],"award-info":[{"award-number":["EGAN641558"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["PIOTRO20F0"],"award-info":[{"award-number":["PIOTRO20F0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["PIOTRO21F5"],"award-info":[{"award-number":["PIOTRO21F5"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["EGAN641558"],"award-info":[{"award-number":["EGAN641558"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32 DK007276"],"award-info":[{"award-number":["T32 DK007276"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00adh9b73","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32 DK007276"],"award-info":[{"award-number":["T32 DK007276"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/00adh9b73","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases","id":[{"id":"https:\/\/ror.org\/00adh9b73","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The in vivo efficacy of polymeric nanoparticles (NPs) is dependent on their pharmacokinetics, including time in circulation and tissue tropism. Here we explore the structure-function relationships guiding physiological fate of a library of poly(amine-co-ester) (PACE) NPs with different compositions and surface properties. We find that circulation half-life as well as tissue and cell-type tropism is dependent on polymer chemistry, vehicle characteristics, dosing, and strategic co-administration of distribution modifiers, suggesting that physiological fate can be optimized by adjusting these parameters. Our high-throughput quantitative microscopy-based platform to measure the concentration of nanomedicines in the blood combined with detailed biodistribution assessments and pharmacokinetic modeling provides valuable insight into the dynamic in vivo behavior of these polymer NPs. Our results suggest that PACE NPs\u2014and perhaps other NPs\u2014can be designed with tunable properties to achieve desired tissue tropism for the in vivo delivery of nucleic acid therapeutics. These findings can guide the rational design of more effective nucleic acid delivery vehicles for in vivo applications.<\/jats:p>","DOI":"10.1038\/s41467-024-48442-7","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T09:01:52Z","timestamp":1716022912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Enhancing in vivo cell and tissue targeting by modulation of polymer nanoparticles and macrophage decoys"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4555-3234","authenticated-orcid":false,"given":"Alexandra S.","family":"Piotrowski-Daspit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura G.","family":"Bracaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3701-2714","authenticated-orcid":false,"given":"David A.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Richfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-8957","authenticated-orcid":false,"given":"Thomas C.","family":"Binns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9666-4394","authenticated-orcid":false,"given":"Ryland D.","family":"Mortlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5990-1071","authenticated-orcid":false,"given":"Jordan S.","family":"Pober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-549X","authenticated-orcid":false,"given":"W. Mark","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"48442_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.addr.2020.06.014","volume":"156","author":"AS Piotrowski-Daspit","year":"2020","unstructured":"Piotrowski-Daspit, A. S., Kauffman, A. C., Bracaglia, L. G. & Saltzman, W. M. Polymeric vehicles for nucleic acid delivery. Adv. Drug Deliv. Rev. 156, 119\u2013132 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"48442_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1021\/acs.nanolett.9b04426","volume":"20","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y. et al. Quantitating endosomal escape of a library of polymers for mRNA delivery. Nano Lett. 20, 1117\u20131123 (2020).","journal-title":"Nano Lett."},{"key":"48442_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.biomaterials.2018.05.043","volume":"176","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. A \u201ctop-down\u201d approach to actuate poly(amine-co-ester) terpolymers for potent and safe mRNA delivery. Biomaterials 176, 122\u2013130 (2018).","journal-title":"Biomaterials"},{"key":"48442_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120780","volume":"272","author":"MK Grun","year":"2021","unstructured":"Grun, M. K. et al. PEGylation of poly(amine-co-ester) polyplexes for tunable gene delivery. Biomaterials 272, 120780 (2021).","journal-title":"Biomaterials"},{"key":"48442_CR5","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1073\/pnas.1620874114","volume":"114","author":"JE Dahlman","year":"2017","unstructured":"Dahlman, J. E. et al. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc. Natl. Acad. Sci. USA 114, 2060\u20132065 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48442_CR6","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","volume":"19","author":"B Ouyang","year":"2020","unstructured":"Ouyang, B. et al. The dose threshold for nanoparticle tumour delivery. Nat. Mater. 19, 1362\u20131371 (2020).","journal-title":"Nat. Mater."},{"key":"48442_CR7","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41551-020-0581-2","volume":"4","author":"MP Nikitin","year":"2020","unstructured":"Nikitin, M. P. et al. Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes. Nat. Biomed. Eng. 4, 717\u2013731 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"48442_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23140-9","volume":"8","author":"M Germain","year":"2018","unstructured":"Germain, M. et al. Priming the body to receive the therapeutic agent to redefine treatment benefit\/risk profile. Sci. Rep. 8, 4797 (2018).","journal-title":"Sci. Rep."},{"key":"48442_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16293-6","volume":"7","author":"L Liu","year":"2017","unstructured":"Liu, L. et al. A new approach to deliver anti-cancer nanodrugs with reduced off-target toxicities and improved efficiency by temporarily blunting the reticuloendothelial system with intralipid. Sci. Rep. 7, 16106 (2017).","journal-title":"Sci. Rep."},{"key":"48442_CR10","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1021\/acs.biomac.8b00997","volume":"19","author":"AC Kauffman","year":"2018","unstructured":"Kauffman, A. C. et al. Tunability of biodegradable poly(amine- co-ester) polymers for customized nucleic acid delivery and other biomedical applications. Biomacromolecules 19, 3861\u20133873 (2018).","journal-title":"Biomacromolecules"},{"key":"48442_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jconrel.2019.04.044","volume":"304","author":"J Cui","year":"2019","unstructured":"Cui, J. et al. Poly(amine-co-ester) nanoparticles for effective Nogo-B knockdown in the liver. J. Control. Release 304, 259\u2013267 (2019).","journal-title":"J. Control. Release"},{"key":"48442_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00297-x","volume":"8","author":"J Cui","year":"2017","unstructured":"Cui, J. et al. Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells. Nat. Commun. 8, 191 (2017).","journal-title":"Nat. Commun."},{"key":"48442_CR13","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1073\/pnas.1915450117","volume":"117","author":"LG Bracaglia","year":"2020","unstructured":"Bracaglia, L. G. et al. High-throughput quantitative microscopy-based half-life measurements of intravenously injected agents. Proc. Natl. Acad. Sci. 117, 3502\u20133508 (2020).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"48442_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jconrel.2019.09.020","volume":"314","author":"HK Mandl","year":"2019","unstructured":"Mandl, H. K. et al. Optimizing biodegradable nanoparticle size for tissue-specific delivery. J. Control. Release 314, 92\u2013101 (2019).","journal-title":"J. Control. Release"},{"key":"48442_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1021\/acs.nanolett.2c04479","volume":"23","author":"A Radmand","year":"2023","unstructured":"Radmand, A. et al. The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo. Nano Lett. 23, 993\u20131002 (2023).","journal-title":"Nano Lett."},{"key":"48442_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0522","volume":"8","author":"AS Piotrowski-Daspit","year":"2022","unstructured":"Piotrowski-Daspit, A. S. et al. In vivo correction of cystic fibrosis mediated by PNA nanoparticles. Sci. Adv. 8, eabo0522 (2022).","journal-title":"Sci. Adv."},{"key":"48442_CR17","first-page":"162","volume":"10","author":"Z Lin","year":"2016","unstructured":"Lin, Z., Monteiro-Riviere, N. A. & Riviere, J. E. A physiologically based pharmacokinetic model for polyethylene glycol-coated gold nanoparticles of different sizes in adult mice. Nanotoxicology 10, 162\u2013172 (2016).","journal-title":"Nanotoxicology"},{"key":"48442_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12989-022-00489-4","volume":"19","author":"WC Chou","year":"2022","unstructured":"Chou, W. C. et al. Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats. Part. Fibre Toxicol. 19, 47 (2022).","journal-title":"Part. Fibre Toxicol."},{"key":"48442_CR19","doi-asserted-by":"crossref","unstructured":"Li, L. et al. Simulation of the In Vivo Fate of Polymeric Nanoparticles Traced by Environment-Responsive Near-Infrared Dye: A Physiologically Based Pharmacokinetic Modelling Approach. Molecules 26, 1271 (2021).","DOI":"10.3390\/molecules26051271"},{"key":"48442_CR20","doi-asserted-by":"publisher","first-page":"012019","DOI":"10.1088\/1742-6596\/429\/1\/012019","volume":"429","author":"D Li","year":"2013","unstructured":"Li, D., Emond, C., Johanson, G. & Jolliet, O. Using a PBPK model to study the influence of different characteristics of nanoparticles on their biodistribution. J. Phys. Conf. Ser. 429, 012019 (2013).","journal-title":"J. Phys. Conf. Ser."},{"key":"48442_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0002-9343(79)90554-0","volume":"66","author":"ER Eichner","year":"1979","unstructured":"Eichner, E. R. Splenic function: normal, too much and too little. Am. J. Med. 66, 311\u2013320 (1979).","journal-title":"Am. J. Med."},{"key":"48442_CR22","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/blood.V79.3.594.594","volume":"79","author":"PO Iversen","year":"1992","unstructured":"Iversen, P. O., Nicolaysen, G. & Benestad, H. B. Blood flow to bone marrow during development of anemia or polycythemia in the rat. Blood 79, 594\u2013601 (1992).","journal-title":"Blood"},{"key":"48442_CR23","doi-asserted-by":"crossref","unstructured":"Handelsman, Y. & Lepor, N. E. PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review. J. Am. Heart Assoc. 7, e008953 (2018).","DOI":"10.1161\/JAHA.118.008953"},{"key":"48442_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1146\/annurev-med-042716-091351","volume":"69","author":"CN Hess","year":"2018","unstructured":"Hess, C. N., Low Wang, C. C. & Hiatt, W. R. PCSK9 Inhibitors: mechanisms of action, metabolic effects, and clinical outcomes. Annu. Rev. Med. 69, 133\u2013145 (2018).","journal-title":"Annu. Rev. Med."},{"key":"48442_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33490-8","volume":"13","author":"C Albert","year":"2022","unstructured":"Albert, C. et al. Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications. Nat. Commun. 13, 5998 (2022).","journal-title":"Nat. Commun."},{"key":"48442_CR26","doi-asserted-by":"publisher","unstructured":"McCall, R. L. & Sirianni, R. W. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J. Vis. Exp. 51015 https:\/\/doi.org\/10.3791\/51015 (2013).","DOI":"10.3791\/51015"},{"key":"48442_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/wics.56","volume":"2","author":"ST Tokdar","year":"2010","unstructured":"Tokdar, S. T. & Kass, R. E. Importance sampling: a review. WIREs Computational Statistics 2, 54\u201360 (2010).","journal-title":"WIREs Computational Statistics"},{"key":"48442_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan, M. & Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 1, 100086 (2020).","journal-title":"STAR Protoc."},{"key":"48442_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jmb.2011.12.019","volume":"415","author":"A Koide","year":"2012","unstructured":"Koide, A., Wojcik, J., Gilbreth, R. N., Hoey, R. J. & Koide, S. Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold. J. Mol. Biol. 415, 393\u2013405 (2012).","journal-title":"J. Mol. Biol."},{"key":"48442_CR30","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.1073\/pnas.1303640110","volume":"110","author":"F Sha","year":"2013","unstructured":"Sha, F. et al. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains. Proc. Natl. Acad. Sci. USA 110, 14924\u201314929 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"48442_CR31","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1006\/jmbi.1998.2238","volume":"284","author":"A Koide","year":"1998","unstructured":"Koide, A., Bailey, C. W., Huang, X. & Koide, S. The fibronectin type III domain as a scaffold for novel binding proteins. J. Mol. Biol. 284, 1141\u20131151 (1998).","journal-title":"J. Mol. Biol."},{"key":"48442_CR32","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/pro.3148","volume":"26","author":"F Sha","year":"2017","unstructured":"Sha, F., Salzman, G., Gupta, A. & Koide, S. Monobodies and other synthetic binding proteins for expanding protein science. Protein Sci. 26, 910\u2013924 (2017).","journal-title":"Protein Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48442-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48442-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48442-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T09:02:55Z","timestamp":1716022975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48442-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["48442"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-48442-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: A.S.P., M.E.E. and W.M.S. are co-founders of and, at the time of preparing this manuscript, consultants for Xanadu Bio, Inc., W.M.S. is a member of the Board of Directors of Xanadu Bio, Inc., A.S.P., L.G.B., C.A., J.S.P., and W.M.S. are inventors on patent applications related to the work described here. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4247"}}